|
Welcome
|
|
11 February 2012
|
|
|
| home | my details | ISRCTN Register | mRCT | links | information | press |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
| [ Print-friendly version ] |
| Facilitating Implementation of Research Evidence |
| ISRCTN | ISRCTN11598502 |
| ClinicalTrials.gov identifier | |
| Public title | Facilitating Implementation of Research Evidence |
| Scientific title | Facilitating Implementation of Research Evidence: a pragmatic randomised controlled trial with integral qualitative, quantitative and health economic evaluative components |
| Acronym | FIRE |
| Serial number at source | 223646 |
| Study hypothesis |
This study aims to advance understanding about the contribution that facilitation and facilitators can make to translating the findings of research into practice and to study different facilitator models to identify whether it is possible to determine a 'good enough' model of facilitation that can address the complex range of factors that influence the uptake of research evidence within the time and resource constraints of day to day service delivery.
The objectives of the study are to: 1. Extend current knowledge of facilitation as a process for translating research evidence into practice 2. Evaluate the feasibility and effectiveness of two different models of facilitation in promoting the uptake of research evidence on continence promotion 3. To advance current knowledge of guideline implementation in healthcare, with a particular focus on understanding the impact of contextual factors on the processes and outcomes of implementation 4. Implement a pro-active dissemination strategy that complements the design of the study and facilitates the diffusion of the study findings to a wide policy and practice community throughout Europe and beyond |
| Lay summary | |
| Ethics approval |
Added 27/09/2010:
1. UK: South East Wales Research Ethics Committee - Panel D approved on the 21st April 2010 (ref: 10/WSE04/20; CSP No.: 33062) 2. Ireland: Local ethics committee approved on the 2nd March 2010 (ref: ECM 4(u)) 3. Netherlands: National ethical clearance not required for this study 4. Sweden: Local ethics committee approved on the 11th January 2010 (ref: 2009/180631/2; 2009/2:11) |
| Study design | Pragmatic randomised controlled trial |
| Countries of recruitment | Ireland, Netherlands, Sweden, United Kingdom |
| Disease/condition/study domain | Long term nursing care |
| Participants - inclusion criteria |
1. Long term nursing care settings with at least 60 places
2. Publically funded places 3. Residents who are aged 60 years or older 4. Interested in taking part in the study 5. Residents with documented urinary incontinence 6. Participants within each site will include those who have consented to be involved as: 6.1. Facilitators engaged in intervention delivery 6.2. Staff at all levels working in sites delivering care 6.3. Key stakeholders related to sites (e.g. regional administrators, funding agencies) 6.4. Residents and carers |
| Participants - exclusion criteria | Patients with moderate or severe dementia |
| Anticipated start date | 01/03/2010 |
| Anticipated end date | 31/12/2012 |
| Status of trial | Ongoing |
| Patient information material | Not available in web format, please use the contact details below to request a patient information sheet |
| Target number of participants | Total number of patients, 50 per site = 300 per country = total 1,200 |
| Interventions |
Arm 1: guidelines on continence care and an implementation guide (control)
Arm 2: guidelines on continence care and an implementation guide and type A facilitation (a 12 month development programme run by external facilitators using technical facilitation) Arm 3: guidelines on continence care and an implementation guide and type B facilitation (a 24 month development programme run by external facilitators using enabling facilitation) |
| Primary outcome measure(s) | The extent to which the guidelines are implemented, using clear criteria linked to the guidelines. Follow up of outcome data is at 6, 12, 18 and 24 months after the interventions starts in all arms. Process data is also collected thoughout the study. |
| Secondary outcome measure(s) |
Clinical outcomes including:
1. Quality of life 2. Continence status 3. Pad use 4. Health economic analysis Follow up of outcome data is at 6, 12, 18 and 24 months after the interventions starts in all arms. Process data is also collected thoughout the study. |
| Sources of funding | European Commission (Belgium) - The Seventh Framework Programme (FP7) (ref: FP7 223646) |
| Trial website | |
| Publications | |
| Contact name | Prof Kate Seers |
| Address |
RCN Research Institute
School of Health and Social Studies University of Warwick |
| City/town | Coventry |
| Zip/Postcode | CV4 7AL |
| Country | United Kingdom |
| kate.seers@warwick.ac.uk | |
| Sponsor | University of Warwick (UK) |
| Address |
Research Support Services
University House |
| City/town | Coventry |
| Zip/Postcode | CV4 7AL |
| Country | United Kingdom |
| dave.duncan@warwick.ac.uk | |
| Sponsor website: | http://www2.warwick.ac.uk/ |
| Date applied | 04/02/2010 |
| Last edited | 29/09/2010 |
| Date ISRCTN assigned | 16/03/2010 |
|
|
|
|
|
| © 2012 ISRCTN unless otherwise stated. | |
|
|
|
|